People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies*, insulin administration is manually controlled, while hybrid ...
The FDA issued an alert warning diabetes patients and caregivers about potential issues with smartphone alerts for continuous ...
The US FDA warns users of smartphone-linked diabetes devices like CGMs and insulin pumps of potential health risks due to ...
The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such ...
Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.
Some patients with diabetes may be missing critical safety alerts on their phones, the FDA warned on Wednesday.
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible ...
The FDA today issued an alert around a safety concern regarding diabetes devices that rely on smartphones to deliver critical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback